arrow
S

Scott F. Sieg

University System of Ohio
H指数:44
被引数:7,580

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback
2024-07-222
OA
Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial
AIDS
IF3.1
2024-03-135
PRE
Cytomegalovirus Infection Facilitates the Costimulation of CD57+CD28-CD8 T Cells in HIV Infection and Atherosclerosis via the CD2-LFA-3 Axis
2023-12-044
PRE
Viral and host mediators of non-suppressible HIV-1 viremia

不可抑制的HIV-1病毒血症的病毒和宿主介质

2023-11-1313
OAAI
Immune Status and SARS-CoV-2 Viral Dynamics

免疫状态和SARS-CoV-2病毒动态

2023-08-318
OA
Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection
2023-04-0312
OA
Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19
2022-11-116
OAAI
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial
2022-02-1713
OA
CX3CL1 and IL-15 Promote CD8 T cell chemoattraction in HIV and in atherosclerosis
2020-09-2526
OAAI
Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15

IL-15产生并扩增炎症CX3CR1 CD57 CD8 T细胞

2020-05-0539
OA
Altered Lipidome Composition Is Related to Markers of Monocyte and Immune Activation in Antiretroviral Therapy Treated Human Immunodeficiency Virus (HIV) Infection and in Uninfected Persons
2019-04-1639
OAAI